MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Loneliness, Self-Efficacy, and Resilience: Neglected Modifiable Contributors to Parkinson’s Disease Symptom Severity and Quality of Life

    I. Subramanian, B. Mcdaniels, D. Fox, L. Mischley (Los Angeles, USA)

  • Long duration response to levodopa in advanced Parkinson disease

    P. Nieto, A. García, I. Martín, R. Ibañez, JP. Cabello, J. Vaamonde (Ciudad Real, Spain)

  • Long term effects of Deep Brain Stimulation on Camptocormia in Parkinson’s disease

    L. Nessis, C. Oehlwein, M. Oehlwein, W J. Schulz-Schaeffer (Homburg

  • Long term treatment with botulinum neurotoxin for focal dystonia – effect of dose and dilution

    D. Weise, P. Henn, C. Weise (Stadtroda, Germany)

  • Long-term dementia prevalence in Parkinson disease: Glass half-full?

    J. Gallagher, J. Fedler, C. Gochanour, R. Dobkin, D. Aarsland, R. Alcalay, M. Barrett, C. Caspell-Garcia, R. Cho, L. Chahine, A. Chen-Plotkin, C. Coffey, N. Dahodwala, J. Eberling, A. Espay, J. Leverenz, I. Litvan, E. Mamikonyan, J. Morley, I. Richard, L. Rosenthal, A. Siderowf, T. Simuni, M. York, A. Willis, S. Xie, D. Weintraub (Philadelphia, USA)

  • Long-term effectiveness of adjuvant treatment with catechol-o-methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists in Parkinson’s disease uncontrolled by levodopa: final results of the PD MED LATER randomized clinical trial

    C. Clarke, C. Rick, S. Patel, R. Wooley, N. Rowland, J. Futterer, R. Ottridge, C. Jenkinson, R. Gray (Birmingham, United Kingdom)

  • Long-term effects of a mobile technology-based brisk walking program on Parkinsonian symptoms in Parkinson’s disease – a randomized controlled trial

    MKY. Mak, ISK. Wong-Yu (Hong Kong SAR, China)

  • Long-term evolution of advanced Parkinson’s disease burden: second interim results from the international PROSPECT observational study

    P. Sanchez Alonso, O. de Fabregues, A. Lehn, T. Oeda, F. Ory-Magne, D. Safarpour, L. Bergmann, P. Kukreja, K. Onuk, V. Fung (Majadahonda, Spain)

  • Long-term follow up of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration Syndrome: two case reports

    D. Damas, I. Carvalho, S. Caldeira, P. Monteiro, R. Pereira, I. Cunha, F. Moreira (Coimbra, Portugal)

  • Long-term outcomes after subthalamic nucleus deep brain stimulation (STN-DBS) in patients with Parkinson’s Disease (PD) in Singapore

    YZ. Cai, W. Li, Y. Zheng, A. Zhan, HL. Ng, Z. Xu, KY. Tay, WL. Au, L. Tan, WH. Ng, KR. Wan, S. Neo (Singapore, Singapore)

  • « Previous Page
  • 1
  • …
  • 101
  • 102
  • 103
  • 104
  • 105
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley